| ncRNA name | THOR |
| ncRNA Category | lncRNA |
| ID | 100506797 |
| Ensembl | ENSG00000226856 |
| Synonyms | THORLNC |
| Disease name | retinoblastoma (RB) |
| Species | Homo sapiens |
| Tissues/Cell_line | RB samples; human RB cell line WERI‑Rb1 and Y79; human retinal epithelial cell line ARPE-19 |
| Methods | RT-PCR, Western blot, immunoprecipitation, RNA pull down assay, MTT assay, flow cytometry, transwell assay, xenograft |
| Expression pattern | up-regulated |
| Functional description | LncRNA THOR is up-regulated in retinoblastoma, and its over-expression significantly enhances the malignant phenotype transformation of retinoblastoma cells through up-regulating c-myc expression via enhancing its combination with TGF2BP1 protein. |
| PubMed ID | 30119193 |
| Year | 2018 |
| Title | LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.